Choose the brand aligned with your industry so we can best serve your needs.
For researchers, scientists, and technical professionals: Your one-stop shop for the complete range of laboratory, production, and safety products and services.
[Ir(Cp-)Cl2]2 is an organometallic iridium(III) chloride dimer used as a precursor to catalysts for asymmetric transfer hydrogenation of ketones and in the synthesis of amines. It is supplied as an orange to reddish-brown solid for research use and requires light protection and inert storage.
Used as a precursor for asymmetric transfer hydrogenation catalysts.
Applicable in greener amine synthesis reactions.
Orange to reddish-brown solid, suitable for small-scale research.
Store at 4°C, protect from light, and keep under nitrogen for stability.
For research use only; not intended for human or patient use.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
[Ir(Cp-)Cl2]2 (dichloro(pentamethylcyclopentadienyl)iridium(III) dimer) is an organometallic iridium complex supplied for research use. It serves as a precursor to catalysts for asymmetric transfer hydrogenation of ketones and is employed in catalytic amine synthesis. The compound is a solid, typically orange to reddish brown, with formula C20H30Cl4Ir2 and an approximate molecular weight of 796.70 g·mol⁻¹.
High purity ≥99.0% suitable for research and synthetic applications.
Precursor for asymmetric transfer hydrogenation catalysts.
Useful catalyst for greener amine synthesis and related transformations.
Orange to reddish brown solid offering easy handling and storage.
Chemical identity confirmed by CAS number and molecular formula for traceability.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
NecroIr2 is an iridium(III) complex necroptosis inducer active in cisplatin-resistant lung cancer (A549R) cells. It selectively accumulates in mitochondria, triggers oxidative stress and loss of mitochondrial membrane potential, activates RIPK3 and MLKL, and modulates CDK4 expression. Intended for laboratory research use.
Iridium(III) complex with mitochondrial accumulation.
Induces necroptosis in cisplatin-resistant lung cancer cells.
Activates RIPK3 and MLKL signaling pathways.
Causes oxidative stress and loss of mitochondrial membrane potential.
Supplied in multiple pack sizes and high purity for research applications.
Store sealed away from moisture and light; use cold storage for solutions.
Encompass Procurement Services Non-distribution item offered as a customer accommodation; additional freight charges may apply. Learn More
NecroIr1 is an iridium(III) coordination complex used as a research reagent to induce necroptosis in cisplatin-resistant lung cancer cells (A549R). It preferentially accumulates in mitochondria, promotes reactive oxygen species (ROS) generation and loss of mitochondrial membrane potential, activates necroptosis-associated kinases, and induces G0/G1 cell-cycle arrest that inhibits cell proliferation in vitro.
High purity (98.02%) suitable for cellular assays.